Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HeraMED Ltd. ( (AU:HMD) ) just unveiled an announcement.
HeraMED Limited has applied to the ASX for quotation of 41,300,685 new fully paid ordinary shares, to be traded under its existing code HMD. The issuance, tied to previously announced transactions, will expand the company’s quoted share base, potentially affecting liquidity and ownership structure as these new securities commence trading on 4 February 2026.
The most recent analyst rating on (AU:HMD) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on HeraMED Ltd. stock, see the AU:HMD Stock Forecast page.
More about HeraMED Ltd.
YTD Price Performance: 22.22%
Average Trading Volume: 898,607
Technical Sentiment Signal: Buy
Current Market Cap: A$46.02M
For an in-depth examination of HMD stock, go to TipRanks’ Overview page.